You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 10,258,622


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,258,622 protect, and when does it expire?

Patent 10,258,622 protects BRAFTOVI and is included in one NDA.

This patent has forty-six patent family members in thirty-eight countries.

Summary for Patent: 10,258,622
Title:Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-- pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate
Abstract: This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methyl-sulfonamido)phenyl)-1-isopropyl-1H- -pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.
Inventor(s): Verma; Daya (Edison, NJ), Krishnamachari; Yogita (Springfield, NJ), Shen; Xiaohong (Livingston, NJ), Lee; Hanchen (Teaneck, NJ), Li; Ping (Basking Ridge, NJ), Singh; Rajinder (Sewaren, NJ), Tan; LayChoo (Bridgewater, NJ)
Assignee: Array BioPharma Inc. (Boulder, CO)
Application Number:15/452,239
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,258,622: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into the specifics of its scope, claims, and the broader patent landscape. This article will provide a detailed analysis of United States Patent 10,258,622, focusing on its claims, the context within which it was granted, and the implications of its existence in the patent ecosystem.

Patent Overview

United States Patent 10,258,622, like any other patent, is a grant of rights for an invention, issued by the U.S. Patent and Trademark Office (USPTO). To understand this patent, one must first look at its title, abstract, and the detailed description provided in the patent document.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, as they define the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details. For example, in the case of the Cellect patents, claims were analyzed for obviousness-type double patenting (ODP), highlighting the importance of claim structure and dependency[1].

Claim Construction

Claim construction is a critical step in understanding the patent's scope. It involves interpreting the language of the claims to determine what is covered by the patent. This process can be complex and often involves legal and technical expertise. The USPTO and courts use various tools and guidelines to ensure consistent and accurate claim construction.

Patent Scope and Coverage

Patent Scope Measurements

The scope of a patent can be measured using various metrics, such as the number of claims, the breadth of claims, and the dependency between claims. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in assessing the scope of a patent[3].

Technology Field

Understanding the technology field in which the patent operates is essential. Patents are often categorized into broad technology fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and others. This categorization helps in identifying the patent's relevance and impact within its specific domain[4].

Patent Term and Adjustments

Patent Term Adjustment (PTA)

The term of a patent can be adjusted due to delays in the prosecution process. Patent Term Adjustment (PTA) is granted under 35 U.S.C. § 154(b) for delays caused by the USPTO. However, as seen in the Cellect case, PTA does not extend the term of a patent past the date of a terminal disclaimer, which is often used to overcome ODP rejections[1].

Terminal Disclaimers

Terminal disclaimers are used to avoid ODP by disclaiming the term of a later patent that would extend beyond the term of an earlier patent. This ensures that the inventor does not secure a second, later-expiring patent for the same invention, thereby preventing the extension of patent term through multiple filings[1].

Obviousness-Type Double Patenting (ODP)

ODP Analysis

ODP is a doctrine that prevents an inventor from securing multiple patents for the same invention, especially when the patents have different expiration dates due to PTA or other adjustments. The Cellect case illustrates how ODP analysis can lead to the invalidation of claims if they are found to be obvious variants of earlier patents[1].

Impact on Patent Validity

ODP can significantly impact the validity of patent claims. If a patent is found to be an obvious variant of an earlier patent, it may be deemed unpatentable. This highlights the importance of careful claim drafting and strategic patent filing to avoid ODP issues.

Patent Landscape and Competition

Small Claims Patent Court

The patent landscape is also influenced by the availability of legal avenues for dispute resolution. The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), aims to provide a more accessible and cost-effective way for small entities to resolve patent disputes. This could potentially alter the competitive dynamics in various technology fields[5].

Economic Impact

Patents play a crucial role in the economy by incentivizing innovation. The probability of receiving a U.S. patent varies based on factors such as the technology field, the size of the entity filing the patent, and the origin of the application. Understanding these factors can help in assessing the economic impact of a patent like 10,258,622[4].

Industry Expert Insights

Industry experts often provide valuable insights into the patent landscape. For instance, former USPTO directors and legal practitioners have contributed to studies on patent court structures and the methodology for quantitative and qualitative research in patent studies[5].

Illustrative Statistics

  • Patent Application Success Rate: The probability of receiving a U.S. patent varies, but generally, about 50-60% of utility patent applications are granted[4].
  • Patent Scope Metrics: The USPTO's Patent Claims Research Dataset shows that the average number of claims per patent has increased over the years, indicating broader patent scope[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the patent's scope.
  • Patent Term Adjustments: PTA and terminal disclaimers play significant roles in managing the term of a patent.
  • ODP: Obviousness-type double patenting can invalidate claims if they are found to be obvious variants of earlier patents.
  • Patent Landscape: The availability of legal avenues like small claims patent courts can influence the competitive dynamics.
  • Economic Impact: Patents have a significant economic impact, and understanding the factors influencing patent grants is essential.

FAQs

What is the purpose of claims in a patent?

Claims in a patent define the scope of the invention and are crucial for determining what is covered by the patent.

How does Patent Term Adjustment (PTA) affect the term of a patent?

PTA adjusts the term of a patent due to delays in the prosecution process caused by the USPTO, but it does not extend the term past the date of a terminal disclaimer.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine that prevents an inventor from securing multiple patents for the same invention, especially when the patents have different expiration dates.

Why is the concept of a small claims patent court important?

The concept of a small claims patent court aims to provide a more accessible and cost-effective way for small entities to resolve patent disputes, potentially altering the competitive dynamics in various technology fields.

How do industry experts contribute to patent studies?

Industry experts, including former USPTO directors and legal practitioners, contribute to studies on patent court structures and research methodologies, providing valuable insights into the patent landscape.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Claims Research Dataset - USPTO.
  4. What Is the Probability of Receiving a US Patent? - YJOLT.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,258,622

Showing 1 to 2 of 2 entries

International Family Members for US Patent 10,258,622

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 088936 ⤷  Try for Free
Australia 2012340759 ⤷  Try for Free
Brazil 112014011981 ⤷  Try for Free
Canada 2856406 ⤷  Try for Free
Chile 2014001337 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.